| Literature DB >> 33677769 |
Ricardo Mesquita Camelo1,2,3, Camila Caram-Deelder4,5, Bruna Pontes Duarte6, Marilia Carolina Braga de Moura6, Neuza Cavalcanti de Moraes Costa6, Iris Maciel Costa6, Carlos Guilherme Piscoya Roncal6, Ana Maria Vanderlei6, Tania Maria Rocha Guimaraes6,7, Samantha Gouw4,8, Suely Meireles Rezende9, Johanna van der Bom4,5.
Abstract
Since the introduction of episodic and prophylactic treatments with safer factor concentrates, the life expectancy of people with haemophilia (PwH) has improved considerably. Ageing-related diseases such as cardiovascular disease (CVD) have also become more prevalent in PwH. This cross-sectional study aimed to evaluate CVD risk factors and estimate 10-year risk for CVD events among PwH. Male patients ≥ 30 years were interviewed and examined. Blood tests were performed at the local laboratory. Eighty-two patients were included, of whom 83% had haemophilia A and half had severe disease. Median age at study entry was 43.0 years (interquartile range [IQR], 36.0-51.3). Prevalence of obesity, systemic arterial hypertension (SAH) and diabetes mellitus were 16%, 60% and 16%, respectively. Hypertriglyceridaemia, hypercholesterolaemia and low HDL blood levels were present in 18%, 41% and 30% of patients, respectively. Metabolic syndrome was found in 37%. The Framingham Risk Score showed that 39% of PwH had a high risk of developing cardiovascular events in the following 10 years. We conclude that, in this cohort, PwH have a higher prevalence of SAH when compared with Brazilian men without haemophilia and about two-fifths have a high risk of developing a CVD event in the following 10 years.Entities:
Keywords: Cardiovascular disease; Cardiovascular risk; Framingham Risk Score; Haemophilia
Year: 2021 PMID: 33677769 DOI: 10.1007/s12185-021-03104-y
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490